Skip to main content
. 2002 Oct;51(4):536–539. doi: 10.1136/gut.51.4.536

Figure 2.

Figure 2

Suspected adverse reactions for sulphasalazine according to disease indication per million prescriptions for the period 1991–1998 (χ2 test: *p<0.01, ***p<0.001). Only cases with a specific diagnosis of inflammatory bowel disease (IBD) or rheumatoid arthritis were included.